NCT06608004 is a clinical trial of test taking in Amyotrophic Lateral Sclerosis (ALS), sponsored by Centre Hospitalier Universitaire Dijon.

Who is sponsoring NCT06608004?

NCT06608004 is sponsored by Centre Hospitalier Universitaire Dijon.

What drugs are being tested in NCT06608004?

Interventions in NCT06608004: test taking.

What condition does NCT06608004 study?

NCT06608004 studies Amyotrophic Lateral Sclerosis (ALS).

Is NCT06608004 still recruiting?

NCT06608004 is currently recruiting now.

Last reviewed 2026-06-09 · How we verify

NCT06608004

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis

Recruiting now

What this trial tests

trial testing test taking in Amyotrophic Lateral Sclerosis (ALS) in 60 participants. Currently enrolling.

Timeline

12 May 2026

12 May 2029

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Dijon
Status	Recruiting now
Enrollment	60
Start date	12 May 2026
Estimated completion	12 May 2029

Drugs / interventions tested

test taking

Conditions studied

Amyotrophic Lateral Sclerosis (ALS) — all drugs for Amyotrophic Lateral Sclerosis (ALS) →

Sponsor

Centre Hospitalier Universitaire Dijon

Who can join

Eligibility, any sex, with Amyotrophic Lateral Sclerosis (ALS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Amyotrophic Lateral Sclerosis (ALS)

Currently open trials in the same condition.

NCT07187388 — Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neu · NA · recruiting
NCT07233148 — Healing ALS Registry Observational Study (HAROS) · recruiting
NCT07257302 — Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis · NA · recruiting
NCT07118319 — The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Am · Phase 1 · recruiting
NCT07202494 — Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and · recruiting

Other Centre Hospitalier Universitaire Dijon trials

Trials by the same sponsor.

NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT06776848 — A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With · Phase 1, PHASE2 · recruiting
NCT06347302 — Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment · NA · completed
NCT06252415 — Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With C · completed
NCT05939752 — Cardiovascular Complications of Ibrutinib Therapy · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06608004 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Dijon
Last refreshed: recently

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06608004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing